Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, et al.
Journal of the American Heart Association (2020) Vol. 10, Iss. 3
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
David Ahern, Zhichao Ai, Mark Ainsworth, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 916-938.e58
Open Access | Times Cited: 253
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
Douglas B. Kell, Gert Jacobus Laubscher, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 4, pp. 537-559
Open Access | Times Cited: 209
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 139
Clinical characteristics of Egyptian male patients with COVID‐19 acute respiratory distress syndrome
Ahmed S. Doghish, Walid F. Elkhatib, Essam A. Hassan, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0249346-e0249346
Open Access | Times Cited: 68
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Luis Ortega‐Paz, Mattía Galli, Davide Capodanno, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2021) Vol. 8, Iss. 7, pp. 677-686
Open Access | Times Cited: 65
Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
Samantha Cooper, Eleanor Boyle, S Jefferson, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8255-8255
Open Access | Times Cited: 58
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Endothelial Glycocalyx Degradation in Critical Illness and Injury
Eric K. Patterson, Gediminas Cepinskas, Douglas D. Fraser
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 46
Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management
Henry Sutanto, Gatot Soegiarto
Hematology Reports (2023) Vol. 15, Iss. 2, pp. 225-243
Open Access | Times Cited: 34


Revista de Hematología (2024) Vol. 24, Iss. 3
Open Access | Times Cited: 7
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19
Xin Hu, Jonathan H. Shrimp, Hui Guo, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 3, pp. 1124-1135
Open Access | Times Cited: 50
Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases
Emily M. Eichenberger, Amanda C. Coniglio, Carmelo A. Milano, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 41, Iss. 10, pp. 1376-1381
Open Access | Times Cited: 31
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era
Daniel Mieres‐Castro, Freddy Mora
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 348-348
Open Access | Times Cited: 17
Gold-iron oxide nanoparticle: A unique multimodal theranostic approach for thrombosis
Najma Annuria Fithri, Yuao Wu, Gary Cowin, et al.
Applied Materials Today (2023) Vol. 31, pp. 101750-101750
Open Access | Times Cited: 15
Thromboinflammation in COVID-19: Unraveling the interplay of coagulation and inflammation
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu
Medicine (2024) Vol. 103, Iss. 28, pp. e38922-e38922
Open Access | Times Cited: 5
COVID-19
Robert Fong
Perioperative Medicine (2025), pp. 227-246
Open Access
Why All the Fury over Furin?
Essam Eldin A. Osman, Alnawaz Rehemtulla, Nouri Neamati
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2747-2784
Closed Access | Times Cited: 37
COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry
Stefano Fumagalli, Caterina Trevisan, Susanna Del Signore, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 01, pp. 105-112
Open Access | Times Cited: 32
Myocardial Oedema as a Consequence of Viral Infection and Persistence—A Narrative Review with Focus on COVID-19 and Post COVID Sequelae
N Panagiotides, Michael Poledniczek, Martin Andreas, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 121-121
Open Access | Times Cited: 4
The Right Ventricle in COVID-19
Jean Bonnemain, Zied Ltaief, Lucas Liaudet
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2535-2535
Open Access | Times Cited: 28
COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on “Two-Path Unifying Theory” of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy
Jae C. Chang
Vascular Health and Risk Management (2021) Vol. Volume 17, pp. 273-298
Open Access | Times Cited: 28
Acute and Chronic Effects of COVID-19 on the Cardiovascular System
Víctor Arévalos, Luis Ortega‐Paz, Juan José Rodríguez-Arias, et al.
Journal of Cardiovascular Development and Disease (2021) Vol. 8, Iss. 10, pp. 128-128
Open Access | Times Cited: 28
Pathology findings in pediatric patients with COVID-19 and kidney dysfunction
Eric Nomura, Laura S. Finn, Abbie Bauer, et al.
Pediatric Nephrology (2022) Vol. 37, Iss. 10, pp. 2375-2381
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top